PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Read More…
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Phone561-526-4444
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$283.42 million
Profitability
Miscellaneous
Employees187
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable
Petmed Express (NASDAQ:PETS) Frequently Asked Questions
What is Petmed Express' stock symbol?
Petmed Express trades on the NASDAQ under the ticker symbol "PETS."
How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?
Petmed Express announced a quarterly dividend on Tuesday, January 21st. Shareholders of record on Monday, February 3rd will be given a dividend of $0.27 per share on Friday, February 14th. This represents a $1.08 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date of this dividend is Friday, January 31st. View Petmed Express' Dividend History.
How were Petmed Express' earnings last quarter?
Petmed Express Inc (NASDAQ:PETS) released its earnings results on Tuesday, January, 21st. The company reported $0.34 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.30 by $0.04. The company earned $59.92 million during the quarter, compared to analysts' expectations of $61.31 million. Petmed Express had a net margin of 9.28% and a return on equity of 19.91%. The firm's revenue for the quarter was down .2% on a year-over-year basis. During the same period in the previous year, the business earned $0.38 earnings per share. View Petmed Express' Earnings History.
When is Petmed Express' next earnings date?
What price target have analysts set for PETS?
2 brokers have issued 1-year price targets for Petmed Express' shares. Their forecasts range from $20.00 to $31.00. On average, they expect Petmed Express' share price to reach $25.50 in the next year. This suggests that the stock has a possible downside of 5.7%. View Analyst Price Targets for Petmed Express.
What is the consensus analysts' recommendation for Petmed Express?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.
Has Petmed Express been receiving favorable news coverage?
News headlines about PETS stock have been trending negative on Thursday, InfoTrie reports. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Petmed Express earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Petmed Express.
Are investors shorting Petmed Express?
Petmed Express saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 6,200,000 shares, a decline of 10.0% from the January 15th total of 6,890,000 shares. Based on an average daily trading volume, of 585,600 shares, the short-interest ratio is presently 10.6 days. Approximately 32.1% of the company's shares are sold short. View Petmed Express' Current Options Chain.
Who are some of Petmed Express' key competitors?
What other stocks do shareholders of Petmed Express own?
Who are Petmed Express' key executives?
Petmed Express' management team includes the folowing people:
- Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
- Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
- Ms. Alison Berges, Corp. Sec. & Gen. Counsel
Who are Petmed Express' major shareholders?
Petmed Express' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (8.02%), State Street Corp (3.80%), Man Group plc (3.25%), Bank of New York Mellon Corp (1.97%), Personal Capital Advisors Corp (1.54%) and Geode Capital Management LLC (1.47%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni and Robert C Schweitzer. View Institutional Ownership Trends for Petmed Express.
Which major investors are selling Petmed Express stock?
PETS stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Newtyn Management LLC, UBS Group AG, Penserra Capital Management LLC, State Street Corp, Inlet Private Wealth LLC, Bank of New York Mellon Corp and Cubist Systematic Strategies LLC. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom and Gian Fulgoni. View Insider Buying and Selling for Petmed Express.
Which major investors are buying Petmed Express stock?
PETS stock was purchased by a variety of institutional investors in the last quarter, including Citigroup Inc., FMR LLC, Goldman Sachs Group Inc., Man Group plc, Personal Capital Advisors Corp, Oxford Asset Management LLP, Chicago Equity Partners LLC and Cairn Investment Group Inc.. View Insider Buying and Selling for Petmed Express.
How do I buy shares of Petmed Express?
Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Petmed Express' stock price today?
One share of PETS stock can currently be purchased for approximately $27.05.
How big of a company is Petmed Express?
What is Petmed Express' official website?
How can I contact Petmed Express?
Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.
MarketBeat Community Rating for Petmed Express (NASDAQ PETS)
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
